Related Experiment Videos
Design of a laminar flow chamber to study platelet aggregation
Summary
A novel flow chamber allows simultaneous testing of three artificial cardiovascular materials for thrombogenicity. This system quantizes platelet aggregation under conditions mimicking thrombus formation, aiding material selection in surgery.
Area of Science:
- Biomaterials Science
- Cardiovascular Surgery
- Hemodynamics
Background:
- Artificial materials are increasingly used in cardiovascular surgery.
- Assessing the thrombogenic potential of these materials is crucial for patient safety.
- Existing methods may not fully replicate in vivo conditions for material evaluation.
Purpose of the Study:
- To develop and validate a new flow chamber system for evaluating the thrombogenicity of artificial cardiovascular materials.
- To enable simultaneous testing of multiple materials under controlled flow conditions.
- To provide a quantitative method for assessing platelet aggregation on tested materials.
Main Methods:
- A methacrylate flow chamber designed with conical inflow/outflow and a central cylinder.
- The chamber accommodates three material samples for simultaneous testing.
- The system can be used in ex vivo (animal model) or in vitro (perfusion pump) configurations.
- Platelet aggregation is quantified using 111In-oxine labeling.
Main Results:
- The flow chamber facilitates laminar flow, mimicking physiological conditions.
- It allows for the simultaneous evaluation of three distinct biomaterials.
- The system effectively simulates conditions conducive to platelet thrombus formation.
- Quantitative assessment of platelet aggregation on each material is achievable.
Conclusions:
- The developed flow chamber is a valuable tool for assessing the thrombogenicity of cardiovascular biomaterials.
- Its design allows for simultaneous, controlled, and quantitative evaluation.
- This system can aid in the selection of safer artificial materials for cardiovascular surgery.